Sodium butyrate restores ASC expression and induces apoptosis in LS174T cells

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1431-1437

  Zhang, Shuai ^a   Bai, Jingqiao ^a   Ren, Shuangyi ^a   Wang, Ran ^a   Zhang, Li ^a   Zuo, Yunfei ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis associated speck like protein; LS174T cells; Sodium butyrate

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; BUTYRIC ACID; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; COLON CANCER; COLON CARCINOMA; DNA CONFORMATION; EPIGENETICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTYRIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CYTOSKELETAL PROTEINS; GENE EXPRESSION; HUMANS; RNA, MESSENGER; UP-REGULATION;

EID: 84869453799     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1156     Document Type: Article

References (42)

1. Sung JJ, Lau JY, Goh KL, Leung WK; the Asia Pacific Working Group on Colorectal Cancer: Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 11: 871-876, 2005. (Pubitemid 41614799)
2. Jullumstrø E, Wibe A, Lydersen S and Edna TH: Colon cancer incidence, presentation, treatment and outcomes over 25 years. Colorectal Dis 13: 512-518, 2011.
3. Boyle PP and Langman JS: ABC of colorectal cancer: epidemiology. BMJ 321: 805-808, 2000.
4. Fearnhead NS, Wilding JL and Bodmer WF: Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 64: 27-43, 2002. (Pubitemid 35238577)
5. Du W, Li WY, Lu R and Fang JY: Folate and fiber in the prevention of colorectal cancer: between shadows and the light. World J Gastroenterol 16: 921-926, 2010.
6. Bordonaro M, Lazarova DL and Sartorelli AC: Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 7: 1178-1183, 2008. (Pubitemid 351749270)
7. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T and Kelly WK: Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1: 194-202, 2001. (Pubitemid 33741894)
8. Meinke PT and Liberator P: Histone deacetylase: a target for antiproliferative and antiprotozoal agents. Curr Med Chem 8: 211-235, 2001. (Pubitemid 32416448)
9. Weidle UH and Grossmann A: Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res 20: 1471-1485, 2000. (Pubitemid 30628153)
10. Bukreeva EI, Aksenov ND, Bardin AA, Pospelov VA and Pospelova TV: Effect of histone deacetylase inhibitor sodium butyrate (NaB) on transformants E1a + cHa-Ras expressing wild-type p53 with suppressed transactivation function. Tsitologiia 51: 697-705, 2009 (In Russian).
11. Uchida H, Maruyama T, Arase T, Ono M, Nagashima T, Masuda H, Asada H and Yoshimura Y: Histone acetylation in reproductive organs: significance of histone deacetylase inhibitors in gene transcription. Reprod Med Biol 4: 115-122, 2005. (Pubitemid 40903157)
12. Cedar H and Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304, 2009.
13. Bouchier-Hayes L and Martin SJ: CARD games in apoptosis and immunity. EMBO Rep 3: 616-621, 2002.
14. Stone AR, Bobo W, Brat DJ, Devi NS, Van Meir EG and Vertino PM: Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol 165: 1151-1161, 2004. (Pubitemid 39297722)
15. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, et al: Aberrant methylation of TMS1 in small-cell, non-small cell lung cancer and breast cancer. Int J Cancer 106: 198-204, 2003. (Pubitemid 36835171)
16. McCabe MT, Brandes JC and Vertino PM: Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res 15: 3927-3937, 2009.
17. Wilson AJ, Byun DS, Popova N, Murray LB, L'Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH and Mariadason JM: Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281: 13548-13558, 2006. (Pubitemid 43855268)
18. McConnell BB and Vertino PM: TMS1/ASC: the cancer connection. Apoptosis 9: 5-18, 2004. (Pubitemid 38270424)
19. Karin M, CaoY, Greten FR and Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310, 2002. (Pubitemid 37328783)
20. Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi M, Ekström TJ and Szyf M: Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 73: 1297-1307, 2007. (Pubitemid 46452588)
21. Fraga MF, Uriol E, Borja Diego L, Berdasco M, Esteller M, Cañal MJ and Rodríguez R: High-performance capillary electrophoretic method for the quantification of 5-methyl-2′-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues. Electrophoresis 23: 1677-1681, 2002. (Pubitemid 34732445)
22. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K and Herman JG: Aberrant patterns of DNA methylation, chromation and gene expression in cancer. Hum Mol Genet 10: 687-692, 2001. (Pubitemid 32331576)
23. Zhou M, Li P, Tan L, Qu S, Ying QL and Song H: Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J Cell Biochem 109: 606-614, 2010.
24. Ren M, Yan L, Shang CZ, Cao J, Lu LH, Min J and Cheng H: Effects of sodium butyrate on the differentiation of pancreatic and hepatic progenitor cells from mouse embryonic stem cells. J Cell Biochem 109: 236-244, 2010.
25. Bartels M, Geest CR, Bierings M, Buitenhuis M and Coffer PJ: Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation. Haematology 95: 1052-1060, 2010.
26. Marks PA, Richon VM and Rifkind RA: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92: 1210-1216, 2000. (Pubitemid 30627729)
27. Piekarz R and Bates S: A review of depsipeptide and other histone deacetylase inhibitors in clinical trials. Curr Pharm Des 10: 2289-2298, 2004. (Pubitemid 38855037)
28. Cho HJ, Kim SY, Kim KH, Kang WK, Kim JI, Oh ST, Kim JS and An CH: The combination effect of sodium butyrate and 5-Aza-2′-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol 7: 49, 2009.
29. Pan L, Matloob AF, Du J, Pan H, Dong Z, Zhao J, Feng Y, Zhong Y, Huang B and Lu J: Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J 277: 989-999, 2010.
30. Cayo MA, Cayo AK, Jarjour SM and Chen H: Sodium butyrate activates Notch1 signaling, reduces tumor markers and induces cell cycle arrest and apoptosis in pheochromocytoma. Am J Transl Res 1: 178-183, 2009.
31. Küster K, Grötzinger C, Koschel A, Fischer A, Wiedenmann B and Anders M: Sodium butyrate increases expression of the coxsackie and adenovirus receptor in colon cancer cells. Cancer Invest 28: 268-274, 2010.
32. Wang L, Luo HS and Xia H: Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway. J Int Med Res 37: 803-811, 2009.
33. Heerdt BG, Houston MA, Anthony GM and Augenlicht LH: Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. Cancer Res 59: 1584-1591, 1999. (Pubitemid 29160130)
34. Yan L, Yang X and Davidson NE: Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer. J Mammary Gland Biol Neoplasia 6: 183-192, 2001. (Pubitemid 39600509)
35. Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R and Hersch SM: Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23: 9418-9427, 2003. (Pubitemid 37323042)
36. Chopin V, Toillon RA, Jouy N and Le Bourhis X: P21waf1/cip1 is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23: 21-29, 2004. (Pubitemid 38142236)
37. Fukasawa K: P53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta 1786: 15-23, 2008.
38. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, Meng S and Hodin RA: The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 289: G696 -G703, 2005.
39. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG and Davidson NE: Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61: 7025-7029, 2001. (Pubitemid 32946489)
40. Nimmanapalli R, O'Bryan E, Huang M, Bali P, Burnette PK, Loughran T, Tepperberg J, Jove R and Bhalla K: Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17- demethoxygeldanamycin. Cancer Res 62: 5761-5769, 2002. (Pubitemid 35204733)
41. Heinzel T and Krämer OH: Pharmacodynamic markers for histone deacetylase inhibitor development. Drug Discov Today Dis Mech 4: 277-283, 2007.
42. Yamaguchi K, Lantowski A, Dannenberg AJ and Subbaramaiah K: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem 280: 32569-32577, 2005. (Pubitemid 41368298)